S&P 500   3,831.70 (+0.06%)
DOW   31,063.14 (-1.08%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
S&P 500   3,831.70 (+0.06%)
DOW   31,063.14 (-1.08%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
S&P 500   3,831.70 (+0.06%)
DOW   31,063.14 (-1.08%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
S&P 500   3,831.70 (+0.06%)
DOW   31,063.14 (-1.08%)
QQQ   315.56 (+0.87%)
AAPL   123.01 (+1.67%)
MSFT   233.36 (+1.91%)
FB   262.43 (+3.04%)
GOOGL   2,029.08 (+0.65%)
AMZN   3,076.47 (+0.63%)
TSLA   676.97 (-0.77%)
NVDA   547.08 (+2.78%)
BABA   239.97 (-0.09%)
CGC   32.50 (-2.14%)
GE   12.64 (-0.94%)
MU   91.32 (+3.63%)
NIO   46.36 (-0.96%)
AMD   84.29 (+2.27%)
T   28.02 (-2.13%)
F   11.75 (-0.09%)
ACB   10.67 (-1.39%)
DIS   189.17 (-0.95%)
BA   212.07 (-2.02%)
NFLX   541.19 (-1.01%)
BAC   35.01 (-2.56%)
Log in
NASDAQ:CLLS

Cellectis Short Interest Ratio and Short Volume

$21.18
+0.54 (+2.62 %)
(As of 02/26/2021 02:27 PM ET)
Add
Compare
Today's Range
$20.17
Now: $21.18
$22.05
50-Day Range
$21.94
MA: $27.97
$33.25
52-Week Range
$7.32
Now: $21.18
$34.71
Volume40,479 shs
Average Volume456,891 shs
Market Capitalization$899.85 million
P/E RatioN/A
Dividend YieldN/A
Beta2.59

Short Interest

Cellectis (NASDAQ:CLLS) Short Interest Data

Current Short Volume438,700 shares
Previous Short Volume614,200 shares
Change Vs. Previous Month:-28.57%
Dollar Volume Sold Short$11.52 million
Short Interest Ratio / Days to Cover1.0
Last Record DateJanuary, 29 2021
Outstanding Shares42,450,000 shares
Float Size42,060,000 shares
Short Percent of Float1.04%
Today's Trading Volume40,479 shares
Average Trading Volume456,891 shares
Today's Volume Vs. Average-91.14%

Short Interest Over Time


Cellectis (NASDAQ:CLLS) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/29/2021438,700 shares $11.52 million -28.6%1.0%1 $26.27
1/15/2021614,200 shares $17.35 million -21.5%1.5%1.7 $28.25
12/31/2020878,100 shares $24.18 million -3.6%2.1%3.1 $27.54
12/15/2020878,100 shares $23.87 million -3.6%2.1%3.1 $27.18
11/30/2020911,200 shares $24.33 million -10.7%2.2%4.6 $26.70
11/15/20201,020,000 shares $25.88 million +20.8%2.4%5.8 $25.37
10/30/2020844,700 shares $16.15 million +16.8%2.0%4.9 $19.12
10/15/2020723,400 shares $12.62 million +28.2%1.7%4.5 $17.44
9/30/2020564,200 shares $11.74 million -0.5%1.3%3.7 $20.80
9/15/2020567,100 shares $10.12 million +4.8%1.3%3.7 $17.85
8/31/2020540,900 shares $9.36 million +18.4%1.3%3.2 $17.30
8/14/2020456,800 shares $8.42 million +32.1%1.1%2.4 $18.44
7/31/2020345,700 shares $5.97 million -0.1%0.8%1.6 $17.27
7/15/2020345,900 shares $5.43 million -3.7%0.8%1.6 $15.70
6/30/2020359,300 shares $5.90 million +39.9%0.9%1.7 $16.42
6/15/2020256,900 shares $4.70 million -16.9%0.6%1.2 $18.31
5/29/2020309,200 shares $5.66 million -8.0%0.7%1.6 $18.29
5/15/2020336,000 shares $6.21 million -5.8%0.8%1.9 $18.47
4/30/2020356,700 shares $6.73 million +34.4%0.8%2.4 $18.87
4/15/2020265,400 shares $4.04 million +21.2%0.6%1.8 $15.22
3/31/2020218,900 shares $2.64 million -35.3%0.5%1.6 $12.06
3/13/2020338,500 shares $3.28 million +5.7%0.8%2.6 $9.70
2/28/2020320,200 shares $2.50 million +13.0%0.8%2.3 $7.81
2/14/2020283,300 shares $3.52 million +8.2%0.7%2.2 $12.42
1/31/2020261,800 shares $4.38 million +15.4%0.6%2 $16.74

Cellectis (NASDAQ:CLLS) Short Interest FAQ

speech bubbles
speech bubbles











What is Cellectis' current short interest?

Short interest is the volume of Cellectis shares that have been sold short but have not yet been closed out or covered. As of January 29th, traders have sold 438,700 shares of CLLS short. 1.04% of Cellectis' shares are currently sold short. View details.

What is a good short interest ratio for Cellectis?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Cellectis currently has a short interest ratio of 1.0.

What is a good short interest percentage for Cellectis?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.04% of Cellectis' floating shares are currently sold short.

Is Cellectis' short interest increasing or decreasing?

Cellectis saw a drop in short interest during the month of January. As of January 29th, there was short interest totaling 438,700 shares, a drop of 28.6% from the previous total of 614,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cellectis' float size?

Cellectis currently has issued a total of 42,486,000 shares. Some of Cellectis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cellectis currently has a public float of 42,060,000 shares.

How does Cellectis' short interest compare to its competitors?

1.04% of Cellectis' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cellectis: NanoString Technologies, Inc. (0.00%), Revolution Medicines, Inc. (8.21%), Editas Medicine, Inc. (0.00%), Sorrento Therapeutics, Inc. (0.00%), AlloVir, Inc. (7.90%), Bavarian Nordic A/S (0.00%), Kymera Therapeutics, Inc. (5.21%), Vericel Co. (0.00%), bluebird bio, Inc. (0.00%), and BioCryst Pharmaceuticals, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Cellectis stock?

Short selling CLLS is an investing strategy that aims to generate trading profit from Cellectis as its price is falling. Cellectis' stock is trading up $0.54 today. To short Cellectis stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Cellectis will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cellectis?

A short squeeze for Cellectis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLLS, which in turn drives the price of the stock up even further.

How often is Cellectis' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLLS, twice per month. The most recent reporting period available is January, 29 2021.



This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.